Recent Stories
-
New grant targets longer-lasting islet cell treatments for type 1 diabetes
Dr Lise Hunault, a researcher in the Centenary Institute’s Centre for Biomedical AI, has been awarded a major research grant from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organisation, to advance islet-cell replacement therapies for type 1 diabetes.News Type: Research NewsDate -
Centenary marks International Women’s Day with inspiring speakers
The Centenary Institute community came together to celebrate International Women’s Day 2026, with a special event highlighting this year’s Australian theme, ‘Balancing the Scales.’News Type: CommunityDate -
Vaxosome launched to develop next-generation mRNA vaccines
A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.News Type: Research NewsDate -
Centenary partners in transformative national liver health program
The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.News Type: Research NewsDate